172 related articles for article (PubMed ID: 25694734)
1. Kavalactone content and chemotype of kava beverages prepared from roots and rhizomes of Isa and Mahakea varieties and extraction efficiency of kavalactones using different solvents.
Wang J; Qu W; Bittenbender HC; Li QX
J Food Sci Technol; 2015 Feb; 52(2):1164-9. PubMed ID: 25694734
[TBL] [Abstract][Full Text] [Related]
2. In vitro inhibition of carboxylesterase 1 by Kava (Piper methysticum) Kavalactones.
Melchert PW; Qian Y; Zhang Q; Klee BO; Xing C; Markowitz JS
Chem Biol Interact; 2022 Apr; 357():109883. PubMed ID: 35278473
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous quantitation of kavalactones in kava dry extracts: comparison of multi-standards and single standard validation approaches.
Ferreira JV; Pierotte IC; Pianetti GA; César IC
Phytochem Anal; 2021 Sep; 32(5):740-748. PubMed ID: 33615586
[TBL] [Abstract][Full Text] [Related]
4. Single-Lab Validation for Determination of Kavalactones and Flavokavains in Piper methysticum (Kava).
Liu Y; Lund JA; Murch SJ; Brown PN
Planta Med; 2018 Nov; 84(16):1213-1218. PubMed ID: 29940660
[No Abstract] [Full Text] [Related]
5. Clinical pharmacokinetics of kavalactones after oral dosing of standardized kava extract in healthy volunteers.
Kanumuri SRR; Mamallapalli J; Nelson R; McCurdy CR; Mathews CA; Xing C; Sharma A
J Ethnopharmacol; 2022 Oct; 297():115514. PubMed ID: 35777607
[TBL] [Abstract][Full Text] [Related]
6. Proposal for a kava quality standardization code.
Teschke R; Lebot V
Food Chem Toxicol; 2011 Oct; 49(10):2503-16. PubMed ID: 21756963
[TBL] [Abstract][Full Text] [Related]
7. Determination of six kavalactones in dietary supplements and selected functional foods containing Piper methysticum by isocratic liquid chromatography with internal standard.
Hu L; Jhoo JW; Ang CY; Dinovi M; Mattia A
J AOAC Int; 2005; 88(1):16-25. PubMed ID: 15759721
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Different Forms of Kava (Piper methysticum) Products by UPLC-MS/MS.
Mamallapalli J; Kanumuri SRR; Corral P; Johnston E; Zhuang C; McCurdy CR; Mathews CA; Sharma A; Xing C
Planta Med; 2022 Nov; 88(14):1348-1359. PubMed ID: 34839465
[TBL] [Abstract][Full Text] [Related]
9. A UHPLC-UV Method Development and Validation for Determining Kavalactones and Flavokavains in
Tang Y; Fields C
Molecules; 2019 Mar; 24(7):. PubMed ID: 30934989
[TBL] [Abstract][Full Text] [Related]
10. Desmethoxyyangonin and dihydromethysticin are two major pharmacological kavalactones with marked activity on the induction of CYP3A23.
Ma Y; Sachdeva K; Liu J; Ford M; Yang D; Khan IA; Chichester CO; Yan B
Drug Metab Dispos; 2004 Nov; 32(11):1317-24. PubMed ID: 15282211
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of commercial kava extracts and kavalactone standards for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells.
Whittaker P; Clarke JJ; San RH; Betz JM; Seifried HE; de Jager LS; Dunkel VC
Food Chem Toxicol; 2008 Jan; 46(1):168-74. PubMed ID: 17822821
[TBL] [Abstract][Full Text] [Related]
12. Methysticin and 7,8-dihydromethysticin are two major kavalactones in kava extract to induce CYP1A1.
Li Y; Mei H; Wu Q; Zhang S; Fang JL; Shi L; Guo L
Toxicol Sci; 2011 Dec; 124(2):388-99. PubMed ID: 21908763
[TBL] [Abstract][Full Text] [Related]
13. Isolation and Purification of Potent Growth Inhibitors from
Van TM; Xuan TD; Minh TN; Quan NV
Molecules; 2018 Jul; 23(8):. PubMed ID: 30065174
[No Abstract] [Full Text] [Related]
14. Monoamine Oxidase Inhibition by Kavalactones from Kava (Piper Methysticum).
Prinsloo D; van Dyk S; Petzer A; Petzer JP
Planta Med; 2019 Oct; 85(14-15):1136-1142. PubMed ID: 31539917
[TBL] [Abstract][Full Text] [Related]
15. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro.
Weiss J; Sauer A; Frank A; Unger M
Drug Metab Dispos; 2005 Nov; 33(11):1580-3. PubMed ID: 16051732
[TBL] [Abstract][Full Text] [Related]
16. Analysis of kavalactones from Piper methysticum (kava-kava).
Bilia AR; Scalise L; Bergonzi MC; Vincieri FF
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 812(1-2):203-14. PubMed ID: 15556499
[TBL] [Abstract][Full Text] [Related]
17. Fourier transform ion cyclotron resonance mass spectrometry for the characterisation of kavalactones in the kava plant: elemental formulae confirmation by dual spray accurate mass measurement and structural confirmation by infrared multiphoton dissociation and sustained off-resonance irradiation collision induced dissociation.
Warburton E; Bristow T
Eur J Mass Spectrom (Chichester); 2006; 12(4):223-33. PubMed ID: 17057279
[TBL] [Abstract][Full Text] [Related]
18. Electrospray high performance liquid chromatography-mass spectrometry in phytochemical analysis of kava (Piper methysticum) extract.
He XG; Lin LZ; Lian LZ
Planta Med; 1997 Feb; 63(1):70-4. PubMed ID: 17252331
[TBL] [Abstract][Full Text] [Related]
19. Kavalactones from Kava (Piper methysticum) root extract as modulators of recombinant human glycine receptors.
Hegazy NH; Breitinger HG; Breitinger U
Biol Chem; 2019 Aug; 400(9):1205-1215. PubMed ID: 31141476
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytic effects of kava extract and kavalactones in the chick social separation-stress paradigm.
Smith KK; Dharmaratne HR; Feltenstein MW; Broom SL; Roach JT; Nanayakkara NP; Khan IA; Sufka KJ
Psychopharmacology (Berl); 2001 Apr; 155(1):86-90. PubMed ID: 11374340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]